Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

Levy, 1984, The influence on lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI type II coronary intervention study, Circulation, 69, 325, 10.1161/01.CIR.69.2.325 Blankenhorn, 1987, Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts, JAMA, 257, 3233, 10.1001/jama.257.23.3233 Buchwald, 1990, Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH), N Engl J Med, 323, 946, 10.1056/NEJM199010043231404 Ornish, 1990, Can lifestyle changes reverse coronary heart disease?, Lancet, 336, 129, 10.1016/0140-6736(90)91656-U Blankenhorn, 1990, The influence of diet on the appearance of new lesions in human coronary arteries, JAMA, 263, 1646, 10.1001/jama.263.12.1646 Brown, 1990, Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein-B, N Engl J Med, 323, 1289, 10.1056/NEJM199011083231901 Kane, 1990, Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens, JAMA, 264, 3007, 10.1001/jama.264.23.3007 Watts, 1992, Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas Atherosclerosis Regression Study (STARS), Lancet, 339, 563, 10.1016/0140-6736(92)90863-X Blankenhorn, 1993, Coronary angiographic changes with lovastatin therapy: the monitored atherosclerosis regression study (MARS), Ann Intern Med, 119, 969, 10.7326/0003-4819-119-10-199311150-00002 Waters, 1994, Effects of monotherapy with an HMG CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: the Canadian Coronary Atherosclerosis Intervention Trial, Circulation, 89, 959, 10.1161/01.CIR.89.3.959 Vos, 1993, Retardation and arrest of progression or regression of coronary artery disease: a review, Prog Cardiovasc Dis, 35, 435, 10.1016/0033-0620(93)90028-C Blankenhorn, 1994, Arterial imaging and atherosclerosis reversal, Arterioscler Thromb, 2, 177, 10.1161/01.ATV.14.2.177 Dumont, 1993, Effect of cholesterol reduction by simvastatin on progression of coronary atheroslerosis, Control Clin Trials, 14, 209, 10.1016/0197-2456(93)90004-W Myers, 1989, The centers for disease control: National Heart Lung and Blood Institute Lipid Standardization Program, Clin Lab Med, 9, 105, 10.1016/S0272-2712(18)30645-0 Boerma, 1986, Minimizing interlaboratory variation in routine assay of serum cholesterol through the use of serum calibrators, Clin Chem, 32, 943, 10.1093/clinchem/32.6.943 Kattermann, 1984, Multicenter study of a new enzymatic method of cholesterol determination, J Clin Chem Clin Biochem, 22, 245 Warnick, 1985, Comparison of improved precipitation methods for quantitation of the high density lipoprotein cholesterol, Clin Chem, 31, 217, 10.1093/clinchem/31.2.217 Bucolo, 1973, Quantitative determination of serum triglycerides by use of enzymes, Clin Chem, 19, 475, 10.1093/clinchem/19.5.476 Friedewald, 1972, Estimation of plasma low-density lipoprotein cholesterol without the use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Reiber, 1985, Assessment of short-, medium- and long-term variations in arterial dimensions from computer assisted quantitation of coronary cineangiograms, Circulation, 71, 280, 10.1161/01.CIR.71.2.280 de Feyter, 1991, Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis: value, limitations, and implications for clinical trials, Circulation, 84, 412, 10.1161/01.CIR.84.1.412 Pocock, 1987, The analysis of multiple endpoints in clinical trials, Biometrics, 43, 487, 10.2307/2531989 Prosser, 1991 Oliver, 1992, Coronary atheroma regression trials, Lancet, 339, 1241, 10.1016/0140-6736(92)91189-F Buchwald, 1994, Disease-free interval assessments after partial ileal bypass in coronary heart disease patients, J Amer Coil Cardiol, 23, 389A Oliver, 1992, Perspective of trials of regression of coronary atherosclerosis, Cardiovasc Risk Factors, 2, 234 Fuster, 1992, Clinical-pathological correlations of coronary disease progression and regression, Circulation, 86, 1111 Davies, 1990, A macro and micro view of coronary vascular insult in ischaemic heart disease, Circulation, 82, 38 Bruschke, 1992, The natural history of angiographically demonstrated coronary artery disease, Eur Heart J, 13, 70, 10.1093/eurheartj/13.suppl_H.70 Report from Committee of Principal Investigators, 1978, A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate, Br Heart J, 40, 1069, 10.1136/hrt.40.10.1069 1984, JAMA, 251, 351, 10.1001/jama.251.3.351 Frick, 1987, Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidaemia, N Engl J Med, 317, 1237, 10.1056/NEJM198711123172001 Holme, 1993, Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis, Br Heart J, 69, S42, 10.1136/hrt.69.1_Suppl.S42